Patents/Inventors

Mohamed-eslam F. Mohamed

Gurnee, ILUS19 patents

19 Patents

US125706642026
Processes for the Preparation of (3s,4r)-3-ethyl-4-(3h-imidazo[1,2-α]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and Solid State Forms Thereof
Abbvie Inc.
0 cites
US123656892025
Processes for the Preparation of (3s,4r)-3-ethyl-4-(3h-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and Solid State Forms Thereof
Abbvie Inc.
0 cites
US121346212024
Processes for the Preparation of (3s,4r)-3-ethyl-4-(3h-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and Solid State Forms Thereof
Abbvie Inc.
0 cites
US121163732024
Processes for the Preparation of (3s,4r)-3-ethyl-4-(3h-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and Solid State Forms Thereof
Abbvie Inc.
0 cites
US121102972024
Processes for the Preparation of (3s,4r)-3-ethyl-4-(3h-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and Solid State Forms Thereof
Abbvie Inc.
0 cites
US121039332024
Processes for the Preparation of (3s,4r)-3-ethyl-4-(3h-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and Solid State Forms Thereof
Abbvie Inc.
0 cites
US120914152024
Processes for the Preparation of (3s,4r)-3-ethyl-4-(3h-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and Solid State Forms Thereof
Abbvie Inc.
0 cites
US120775452024
Processes for the Preparation of (3s,4r)-3-ethyl-4-(3h-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and Solid State Forms Thereof
Abbvie Inc.
0 cites
US119936052024
Processes for the Preparation of (3s,4r)-3-ethyl-4-(3h-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and Solid State Forms Thereof
Abbvie Inc.
0 cites
US119936062024
Processes for the Preparation of (3s,4r)-3-ethyl-4-(3h-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and Solid State Forms Thereof
Abbvie Inc.
0 cites
US119760772024
Processes for the Preparation of (3s,4r)-3-ethyl-4-(3h-imidazo[1,2-α]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and Solid State Forms Therof
Abbvie Inc.
0 cites
US117951752023
Processes for the Preparation of (3s,4r)-3-ethyl-4-(3h-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and Solid State Forms Thereof
Abbvie Inc.
0 cites
US117878152023
Processes for the Preparation of (3s,4r)-3-ethyl-4-(3h-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and Solid State Forms Thereof
Abbvie Inc.
0 cites
US117808472023
Processes for the Preparation of (3s,4r)-3-ethyl-4-(3h-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1- Carboxamide and Solid State Forms Thereof
Abbvie Inc.
0 cites
US117808482023
Processes for the Preparation of (3s,4r)-3-ethyl-4-(3h-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1- Carboxamide and Solid State Forms Thereof
Abbvie Inc.
0 cites
US117731062023
Processes for the Preparation of (3s,4r)-3-ethyl-4-(3h-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and Solid State Forms Thereof
Abbvie Inc.
0 cites
US117673262023
Processes for the Preparation of (3s,4r)-3-ethyl-4-(3h-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and Solid State Forms Thereof
Abbvie Inc.
0 cites
US116074112023
Methods of Treating Crohn's Disease and Ulcerative Colitis
Abbvie Inc.
0 cites
US115649222023
Methods of Treating Crohn's Disease and Ulcerative Colitis
Abbvie Inc.
0 cites